Bellman v. NXP Semiconductors USA, Inc.

248 F. Supp. 3d 1081, 2017 U.S. Dist. LEXIS 48653
CourtDistrict Court, D. New Mexico
DecidedMarch 31, 2017
DocketNo. CIV 16-0113 JB/LAM
StatusPublished
Cited by18 cases

This text of 248 F. Supp. 3d 1081 (Bellman v. NXP Semiconductors USA, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. New Mexico primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bellman v. NXP Semiconductors USA, Inc., 248 F. Supp. 3d 1081, 2017 U.S. Dist. LEXIS 48653 (D.N.M. 2017).

Opinion

MEMORANDUM OPINION AND ORDER

James 0. Browning, UNITED STATES DISTRICT JUDGE

THIS MATTER comes before the Court on the Plaintiffs’ Motion for Remand and Memorandum in Support Thereof, filed March 23,-2016 (Doc. 8)(“Motion”). The Court held a hearing on July 11, 2016. The primary issue is whether the Court should remand the case pursuant to 28 U.S.C. § 1447(c) for, lack of subject matter jurisdiction, because the parties are not completely diverse under , 28 U.S.C. § 1332(a)(1). To decide this issue, the Court must determine whether the Plaintiffs joined Defendant Rinchem Company, Inc.,. a non-diverse party and citizen of New Mexico, fraudulently to defeat federal diversity jurisdiction. The Court concludes that the Plaintiffs have stated possibly via[1091]*1091ble claims against Rinchem Co., and thus, that Rinchem Go. is not fraudulently-joined. Accordingly, because the Court lacks diversity jurisdiction under 28 U.S.C. § 1332(a)(1), the Court will grant the Motion and remand the case to the First Judicial District Court, County of Santa Fe, State of New Mexico.

FACTUAL BACKGROUND

This action involves allegations concerning serious injuries to Plaintiffs Randy Bellman, Jr., Brett Booth, and Brittany Booth, stemming from their mothers’ exposure to chemical products and substances while working at a semiconductor manufacturing plant in Albuquerque, New Mexico. Defendants NXP Semiconductors USA, Inc., Philips Electronics North America Corp., and Philips Semiconductors, Inc. (the “Signetics Defendants”) owned and operated the plant at all times relevant to this action. Rinchem Co. allegedly supplied the chemicals that- the Plaintiffs contend caused their injuries. R. Bellman, Jr., Brett Booth, and Brittany Booth bring negligence, products liability, and warranty claims against the Signetics Defendants and Rinchem Co. Their parents— Plaintiffs Jacqueline Bellman, Randy Bellman, Vicki Goss, and Anthony Booth— bring derivative claims for damages.

The Court takes its recitation of the facts from the Complaint for Personal Injuries, filed February 2, 2016 (Doc. 1-l)(filed January 8, 2016, in Bellman, Jr. v. NXP Semiconductors USA Inc., D-101CV-2016-00045)(“Complaint”). The Court relies on this factual account for background purposes only, particularly because the Signetics Defendants advance several objections to the Complaint’s allegations concerning Rinchem Co. The Court recognizes that the Complaint’s factual account is largely the Plaintiffs’ version of events.

The Court will provide a brief overview of the parties and then review the Complaint’s factual allegations.

1. Overview of the Parties.

R. Bellman, Jr. was born on January 21, 1991. See’ Complaint ¶ 14, at 3. J. Bellman and R. Bellman are his parents. See Complaint ¶ 14, at 3. Brett Booth and Brittany Booth were born on December 29, 1988. See Complaint ¶¶ 15-16, at 3. Brett Booth and Brittany Booth are siblings, and V. Goss and A. Booth are their parents. See Complaint ¶¶ 15-16, at 3.

The Signetics Defendants are foreign corporations organized under the laws of Delaware. See Complaint ¶¶ 8-10, at 2. At all times relevant to this action, the Signet-ics Defendants owned and operated a semiconductor manufacturing facility in Albuquerque. See Complaint ¶ 18, at 3. The Signetics-Defendants operated the facility as “Signetics” or “Signetics Corporation.” Complaint ¶ 18, at 3. Rinchem Co. is a domestic corporation that allegedly supplied, transported, formulated, re-formulated, mixed, sold, and/or distributed chemical products and substances to the Signetics Corp. facility and its employees. See Complaint ¶ 11, at 2; id. ¶¶ 22-23, at 5-6.

2. The Complaint’s Factual Allegations.

From April 1987 to 2000, J. Bellman worked at Signetics Corp.’s Albuquerque facility manufacturing semiconductor products or components. See Complaint ¶ 19, at 3.V. Goss worked at the facility in a similar capacity from July 1983 to 1989. See Complaint ¶ 19, at 3-4, While there, J. Bellman and V. Goss “worked with, in proximity to and/or were exposed to,” a wide variety of chemical products and substances 1 that were used in the manufac[1092]*1092ture of semiconductor products or components. See Complaint ¶ 20, at 4. Rinchem Co. supplied, and Signetics Corp. prescribed, specified, and approved, these chemicals. See Complaint ¶¶23, 26, at 6. Signetics Corp. monitored some of its employees’ exposure to these chemicals; generally monitored its employees’ medical, including reproductive, health; tracked the incidence of adverse reproductive outcomes among its employees’ offspring; and tracked the potential disease burden to its employees and their families that exposure to these chemicals posed. See Complaint ¶¶ 28-31, at 6-7.

The chemicals that Signetics Corp. used included known or suspected teratogenic, genotoxic, and/or reproductively toxic chemical products and/or substances. See Complaint If 33, at 7. Before and during J. Bellman’s and V. Goss’ employment at Sig-netics Corp.’s Albuquerque facility, Signet-ics Corp. had “developed, approved and/or promulgated industrial hygieqe policies and procedures to be followed” at the facility. Complaint ¶37, at 9. These policies “did not include any warnings to workers about the potential for reproductive harm resulting from exposure to the [] chemical[s]” that the facility used, Complaint ¶38, at 9, nor did they include methods, processes, or controls to mitigate excessive exposure to, or standards, regulations, or guidelines to minimize the danger from exposure to, those chemicals, see Corn-plaint ¶¶ 39-41, at 10. Likewise, although Signetics Corp. had training programs for its employees, those programs did not include warnings about reproductive harm that might result from chemical exposure, such as “miscarriage, stillbirth and/or birth defects!] among their offspring.” Complaint ¶¶ 43-44, at 10. Finally, although employees in “wafer processing areas” wore protective equipment, that equipment was designed to protect Signetics Corp.’s semiconductor products/components from particulates and not to protect workers from chemical exposure. Complaint ¶ 51, at 11.

During their periods of gestation, R. Bellman, Jr., Brett Booth, and Brittany Booth all sustained injuries in útero that are linked to them mothers’ exposure to chemicals at Signetics Corp. See Complaint ¶¶ 69-70, at 16. R. Bellman, Jr.’s injuries include pheochromocytoma, Von Hippel-Lindau disease, adrenal gland tumors, other tumors, resection of the adrenal glands, and internal injuries. See Complaint 1176, at 17. Brett Booth’s injuries include congenital heart defects, single ventricle, transportation of the great arteries, and cirrhosis of the liver, resulting in numerous heart surgeries and a heart transplant. See Complaint ¶ 78, at 17. Brittany Booth experiences seizures as a result of her chemical exposure. See Complaint ¶ 80, at 18.

[1093]*1093PROCEDURAL BACKGROUND

The Plaintiffs commenced this action on January 8, 2016, in the First Judicial District Court, County of Santa Fe, State of New Mexico. See Complaint at 1; Bellman, Jr. v. NXP Semiconductors USA Inc., D-101-CV-2016-00045, Register of Actions Activity.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
248 F. Supp. 3d 1081, 2017 U.S. Dist. LEXIS 48653, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bellman-v-nxp-semiconductors-usa-inc-nmd-2017.